Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 39Brain Neoplasms 17Astrocytoma 16Central Nervous System Neoplasms 9Oligodendroglioma 8Gliosarcoma 8Melanoma 7Glioma 7Neoplasms 5Recurrence 4Neoplasm Metastasis 3Neuroblastoma 2Ganglioneuroblastoma 2Diffuse Intrinsic Pontine Glioma 2Choroid Plexus Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Sarcoma, Ewing 1Sarcoma 1Rhabdoid Tumor 1Rare Diseases 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Neuroepithelial 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms, Bone Tissue 1Neoplasms by Histologic Type 1Melanoma, Cutaneous Malignant 1

Interventions

Oxaliplatin 4Sodium Chloride 3Paclitaxel 3Carboplatin 3xaliproden 2Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Magnesium Sulfate 2Leucovorin 2Fluorouracil 2Calcium Gluconate 2neurotropin 1glutamic acid diethyl ester 1Vitamin E 1Thioctic Acid 1Temozolomide 1Saline Solution 1Radiosurgery 1Prednisolone 1Methylprednisolone 1Memantine 1Lamotrigine 1Ketamine 1Glutathione 1Glutamic Acid 1Ginkgo Extract 1Gabapentin 1Duloxetine Hydrochloride 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neurotoxicity Syndromes × Temozolomide × Clear all
NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡